We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Request Information

To request more information about this product, please complete the form below.

Sino Biological ad offering a free HTP antibody production trial until Dec 31, 2025, with “Apply Today” button
Credit: Sino Biological
Request Information
Featured Product
Advertisement

Free Trial for High-throughput Antibody Production

Free Trial for High-throughput Antibody Production
Credit: Sino Biological

Sino Biological's High throughput (HTP) platforms for antibody production offer clients a rapid and cost-effective solution to quickly express a large number of antibodies on a small scale. High-throughput antibody production systems, including mammalian cell expression and cell-free protein synthesis, enable the rapid synthesis of thousands of antibodies per project. Concurrently, Sino Biological provides one-stop analysis platform covering ELISA, SPR/BLI, and physicochemical characterization to thoroughly assess antibody developability.

From now to Dec 31st, 2025, we’re offering a free pilot trail on HTP antibody production for new clients to accelerate your research.


Product Specifications
Mammalian Cell Expression Free Pilot: 3 x 30mL or 3 x 2mg
Cell Free Expression Free Pilot: 3 x 10mL or 3 x 1mg
About Sino Biological
Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and antibody development. All of the products are independently developed and produced, including recombinant proteins, antibodies and cDNA. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements and offers pre-clinical production technology services for monoclonal antibody drug candidates.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.